FDA Inspection
Telix IsoTherapeutics Group, Inc.Telix IsoTherapeutics Group, Inc. – FDA Inspection, Feb 3, 2020
Record Details
This FDA Inspection record concerns Telix IsoTherapeutics Group, Inc., with an inspection on February 3, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 3, 2020
- Product Type
- Drugs
View Company Profile
ID · 3bad0e48-0020-4669-bec4-7c1afc264c17
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1117578
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Telix IsoTherapeutics Group, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2025 | VAI | Dallas District Office | Monitoring of Marketed Animal Drugs, Feeds, and Devices |
| May 17, 2019 | VAI | Dallas District Office | Generic Drug Evaluation |
| November 30, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Telix IsoTherapeutics Group, Inc.
- FDA Inspection 1277105 - 2025-07-31
- FDA Inspection 1089897 - 2019-05-17
- FDA Inspection 994402 - 2016-11-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.